Abstract
Introduction: The handheld Intact Breast Lesion Excision System (Intact) allows radiological excision of an entire breast lesion under ultrasound (USS) guidance for diagnosis and margin assessment. Its use excising benign breast lesions is established, and we have presented data demonstrating it as a reliable and effective tool in this context. The treatment of patients with primary endocrine therapy (PET) is the cause for debate, in particular whether denying surgical excision adversely affects outcome. The aim of the current study was to determine the feasibility of Intact excision of breast cancers from these patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.